U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED AUGUST 31, 2012

FOR THE QUARTERLY PERIOD ENDED FEBRUARY 29, 2012

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______________ TO ______________

FOR THE TRANSITION PERIOD FROM ______________ TO ______________

COMMISSION FILE NUMBER: 0-13187

NVCN CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

Delaware		13-3074570
(State or Other Jurisdiction of Incorporation or Organization)		(IRS Employer Identification No.)
9616 Currell Drive Suite 200 Woodbury, Minnesota		55125
7617 Currell Blvd., Suite 200, Woodbury, Minnesota		55125
(Address of Principal Executive Offices)		(Zip Code)

(612) 750-5855.

(Registrant’s Telephone Number)

~~1800 Wooddale Drive, Suite 208, Woodbury, MN 55125~~NA

(Former Name, Former Address, and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) been subject to such filing requirements for the past 90 days. Yes £o No Tx

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated file, non-accelerated filer, or a smaller reporting company.

Large accelerated filer	o	Accelerated filed	o
Non-accelerated filer	o	Smaller reporting company	x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes T x No £o

As of ~~April~~October 19, 2012 the Registrant had 14,548,371 shares of common stock issued and outstanding

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION
PART I –	FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENT
	BALANCE SHEET AS OF FEBRUARY 29, 2012	4
	BALANCE SHEET AS OF AUGUST 31, 2012	3
	STATEMENT OF OERATIONS FOR THE THREE AND NINE MONTHS ENDED FEBRUARY 29, 2012 AND FEBRUARY 28, 2011 (UNAUDITED)	5
	STATEMENT OF OERATIONS FOR THE THREE MONTS ENDED AUGUST 31, 2012 AND AUGUST 31, 2011 (UNAUDITED)	4
	STATEMENT OF CASH FLOWS FOR NINE MONTHS ENDED FEBRUARY 29, 2012 AND FEBRUARY 28, 2011(UNAUDITED)	6
	STATEMENT OF CASH FLOWS FOR THREE MONTHS ENDED AUGUST 31, 2012 AND AUGUST 31, 2011 (UNAUDITED)	5
	NOTES TO FINANCIAL STATEMENTS	76
ITEM 2.	MANAGMENT DISCUSSION AND ANALYSIS	119
ITEM 3.	QUANATATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS	1210
ITEM 4T.	CONTROLS AND PROCEDURES	1210
PART II – OTHER INFORMATION
PART II –	OTHER INFORMATION
ITEM 1.	LEGAL PROCEEDINGS	1311
ITEM 1A.	RISK FACTORS	1311
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	1311
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	1311
ITEM 4.	[REMOVE AND RESERVE]	1311
ITEM 5.	OTHER INFORMATION	1311
ITEM 6.	EXHIBITS	1311
SIGNATURES		1412

FORWARD LOOKING STATEMENTS

Statements made in this Form 10-Q that are not historical or current facts are forward-looking statements. These statements often can be identified by the use of terms such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate” or “continue,” or the negative thereof. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. Among the factors that could cause actual results to differ materially from the forward-looking statements are the following: the Company’s ability to obtain necessary capital, the Company’s ability to meet anticipated development timelines, the Company’s ability to protect its proprietary technology and knowhow; the Company’s ability to identify and develop a network of physicians, the Company’s ability to establish a global market, clinical trial results, the Company’s ability to successfully consummate future acquisitions and such other risk factors identified from time to time in the Company’s reports filed with the Securities and Exchange Commission, including those filed with this Form 10-Q quarterly report. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

PART I – FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS.

NVCN CORPORATION

BALANCE SHEET

(Unaudited)

	February 29,			May 31,
	August 31,			May 31,
	2012			~~2011~~2012
ASSETS
Current assets
Cash	$	8		$	288
Note receivable		15,000			15,000
Total Assets		15,008		$	15,~~028~~008
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts payable		~~100~~110,~~656~~533			~~102,162~~104407
Accrued interest		1214,~~600~~035			1013,~~447~~317
Accrued compensation- related party		6085,886			2373,386
Notes payable- related parties		5,310			5,310
Notes payable- third party		90,413			8690,413
Total Current Liabilities		~~269~~306,~~865~~177			~~222~~286,~~718~~833
Stockholders’ Deficit
Common stock, $0.001 par value; authorized 50,000,000
shares; issued and outstanding 14,548,371 shares respectively		14,548			14,548
Preferred stock, $0.01 par value authorized 10,000,000
shares; issued and outstanding; none		--			--
Additional paid-in capital		9,335,364			9,335,364
Retained earnings (deficit)		(9,~~604~~641,~~769~~081	)		(9,~~557~~621,~~602~~737	)
Total Stockholders’ Deficit		(~~254~~291,~~857~~169	)		(~~207~~271,~~690~~825	)
Total liabilities and stockholders deficit	$	15,008		$	15,~~028~~008

The accompanying notes are an integral part of the unaudited financial statements

NVCN CORPORATION

STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended						~~Nine Months Ended~~
	February 29			February 28			February 29			February 28
	August 31
	2012			2011			~~2012~~				~~2011~~
Revenue	$	--		$	--		$	--			$	-
Selling, General, and Administrative Expenses		1418,~~995~~627			3312,~~955~~520			~~45,015~~				~~61,744~~
Operating loss		(1412,~~995~~520	)		(3312,~~955~~520	)		~~(45,015~~	)			~~(61,744~~	)
Other income(expense)
Interest expense		(717	)		(~~1,334~~717	)		~~(2,152~~	)			~~(3,374~~	)
Total other income(expense)		(717	)		(~~1,334~~717	)		~~(2,152~~	)			~~(3,374~~	)
Net loss	$	(1519,~~712~~344	)	$	(3513,~~289~~237	)		~~(47,167~~	)			~~(64,118~~	)
Basic and Diluted Loss per Common Share
Net loss	$	(0.00	)	$	(0.0001	)	$	~~(0.00~~	)		$	~~(0.02~~	)
Weighted Average Number of Common Shares
Used to Compute Net loss per Weighted Average Share		14,548,371			1014,~~655~~548,~~993~~371			~~14,548,371~~				~~2,855,505~~

The accompanying notes are an integral part of the unaudited financial statements

NVCN CORPORATION

STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended
	Three Months Ended
	February 29,			February 28,
	August 31,
	2012			2011
Operating Activities
Net Income (Loss) Before Extraordinary Item	$	(4719,~~167~~344	)	$	(6413,~~118~~238	)
Adjustments to Reconcile Net (Loss) to Net Cash
(Required) by Operating Activities:
Accounts payable		(16,~~506~~127	)		~~10,674~~--
Accrued Interest		~~2,153~~717			~~4,642~~718
Accrued compensation-related party		3712,500			(212,~~136~~500	)
Net Cash Required by Operating Activities		~~(9,020~~--	)		(~~50,938~~20	)
Investing Activities:
Investment in notes receivable		--			(15,000	)
Cash given in consideration with stock and other assets for the reduction
Net Cash Required by Investing Activities		--			(15,000	)
of accrued compensation liabilities		--			--
Net Cash Required by Investing Activities		--			--
Financing Activities:
Proceeds(payments) from notes payable – relate parties		5,000			(650	)
Notes payable		--			--
Proceeds from notes payable		4,000			66,600
Net Cash Provided by Financing Activities		--			--
Net Cash Provided by Financing Activities		9,000			65,950
Increase (Decrease) in Cash and Cash Equivalents		--			(20	)
Increase (Decrease) in Cash and Cash Equivalents		(20	)		12
Cash and Cash Equivalents at Beginning Of Period		8			28
Cash and Cash Equivalents at Beginning Of Period		28			16
Cash and Cash Equivalents at End of Period	$	8			8
Cash and Cash Equivalents at End of Period	$	8			28
Supplemental schedules of cash flow information:
Interest paid		--			--
Income Taxes paid		--			--

Nonmonetary Transactions
Stock issued for accounts payable	$	40,000
Stock issued for notes payable	$	86,000
Stock issued for accrued compensation	$	273,000

The accompanying notes are an integral part of the unaudited financial statements

NVCN CORPORATION

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

NOTE 1: BASIS OF PRESENTATION

The accompanying unaudited interim consolidated financial statements of NVCN Corporation (“NVCN”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in NVCN’s May 31, ~~2011~~2012Annual ~~Annual~~ Report filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for the most recent fiscal year end May 31, ~~2011~~2012as as reported on Form 10-K, have been omitted.

NOTE 2: GOING CONCERN CONSIDERATIONS

As shown in the accompanying interim financial statements, the Company has incurred a net loss of $1519,~~712~~344 for the three months ~~and $47,167 for the nine months~~ ending ~~February~~August 2931, 2012. As of ~~February~~August 2931, 2012, the Company reported an accumulated deficit of $9,~~604~~ 641,~~769~~081. The Company has no sales or revenue. The Company’s ability to generate net income and positive cash flows is dependent on the ability to acquire or start an operating entity as well as the ability to raise additional capital. Management is following strategic plans to accomplish these objectives, but success is not guaranteed. As of ~~February~~August 2931, 2012, these factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accounting and reporting policies of the Company conform to U.S. generally accepted accounting principles (US GAAP).

Going Concern

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has no established source of revenue. This matter raises substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

The Company intends to pursue acquisitions of various business opportunities that, in the opinion of management, will provide a profit to the Company; however, the Company does not have the working capital to be successful in this effort or to service its debt. These factors raise substantial doubt about its ability to continue as a going concern.

Continuation of the Company as a going concern is dependent upon obtaining additional working capital and the management of the Company has developed a strategy that it believes will accomplish this objective through additional equity funding which will enable the Company to operate for the coming year. There is no guarantee that additional funding will be obtained or that the Company will be successful in it funding efforts or acquiring any profitable business opportunities.

Basic and Diluted Earnings (Loss) per Share

The Company reports earnings (loss) per share in accordance with ASC 260, "Earnings per Share." Basic earnings (loss) per share are computed by dividing income (loss) available to common stockholders by the weighted average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

The Company has no potential dilutive instruments and accordingly, basic loss and diluted share loss per share are equal.

Estimates and Assumptions

Management uses estimates and assumptions in preparing financial statements in accordance with generally accepted accounting principles. Those estimates and assumptions affect the reported amounts of the assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were assumed in preparing these financial statements.

Statement of Cash Flows

For the purposes of the statement of cash flows, the Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents.

Revenue Recognition

The Company has not recognized any revenues from its operations.

NOTE 4: RECENT ACCOUNTING PRONOUNCEMENTS

InWe ~~January~~do ~~2010,~~not ~~the~~expect ~~FASB issued Accounting Standards Update 2010-01, Equity (Topic 505): Accounting for Distributions to Shareholders with Components of Stock and Cash (A Consensus of~~ the ~~FASB~~adoption ~~Emerging Issues Task Force). This amendment to Topic 505 clarifies the stock portion~~ of arecently ~~distribution~~issued toaccounting ~~shareholders~~pronouncements ~~that allows them~~ to ~~elect~~have ~~to receive cash or stock with~~ a ~~limit~~significant impact on ~~the~~our ~~amount~~results of ~~cash that will be distributed is not a stock dividend for purposes of applying Topics 505 and 260. This ASU is effective for interim and annual periods ending on or after December 15~~operations, ~~2009, and would be applied on a retrospective basis. The Company does not expect the provisions of ASU 2010-01 to have a material effect on the~~ financial position, ~~results of operations~~ or cash ~~flows of the Company~~flow.

In April 2010, the FASB issued Accounting Standard Update No. 2010-13 “Stock Compensation” (Topic 718). ASU No.2010-13 provides amendments to Topic 718 to clarify that an employee share-based payment award with an exercise price denominated in the currency of a market in which a substantial portion of the entity's equity securities trades should not be considered to contain a condition that is not a market, performance, or service condition. Therefore, an entity would not classify such an award as a liability if it otherwise qualifies as equity. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2010. The amendments in this Update should be applied by recording a cumulative-effect adjustment to the opening balance of retained earnings. The cumulative-effect adjustment should be calculated for all awards outstanding as of the beginning of the fiscal year in which the amendments are initially applied, as if the amendments had been applied consistently since the inception of the award. The cumulative-effect adjustment should be presented separately. Earlier application is permitted. The adoption of this guidance has not had and is not expected to have a material impact on the Company’s consolidated financial statements.7

In April 2010, the FASB issued Accounting Standards Update (“ASU” or “Update”) No. 2010–17, “Revenue Recognition - Milestone Method.” The objective of this Update is to provide guidance on defining a milestone and determining when it may be appropriate to apply the milestone method of revenue recognition for research or development transactions. The amendments in this Update are effective on a prospective basis for milestones achieved in fiscal years, and interim periods within those years, beginning on or after June 15, 2010. Early adoption is permitted. The Company does not expect that the adoption of this pronouncement will have a significant effect on its unaudited interim financial statements.

In February 2010, FASB issued ASU No. 2010-09, “Subsequent Events” (Topic 855) Amendments to Certain Recognition and Disclosure Requirements (“ASU 2010-09”). ASU 2010-09 amends disclosure requirements within Subtopic 855-10. An entity that is an SEC filer is not required to disclose the date through which subsequent events have been evaluated. This change alleviates potential conflicts between Subtopic 855-10 and the SEC’s requirements. ASU 2010-09 is effective for interim and annual periods ending after June 15, 2010. The Company does not expect the adoption of ASU 2010-09 to have a material impact on its unaudited interim results of operations or financial position.

In January 2010, the FASB issued ASU No. 2010-06, “Improving Disclosures about Fair Value Measurements” (ASU 2010-06) (codified within ASC 820 Fair Value Measurements and Disclosures). ASU 2010-06 improves disclosures originally required under SFAS No. 157. ASU 2010-06 is effective for interim and annual periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for interim periods within those years. The adoption of the guidance did not have a material effect on the Company's unaudited interim financial position, results of operations, cash flows or related disclosures.

NOTE 5: RELATED PARTY TRANSACTION

As of ~~February~~August 2931, 2012 an outstanding balance of $5,310 was due to the officer as an advance to the Company.

NOTE 6: INCOME TAXES

The Company follows Accounting Standards Codification 740, Accounting for Income Taxes.

Under section 382 of the Internal Revenue Code such a change in control negates much of the tax loss carry forward and deferred income tax. Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax reporting purposes, and (b) net operating loss carry forwards. For federal income tax purposes, the Company uses the accrual basis of accounting, the same that is used for financial reporting purposes.

NOTE 7: COMMITMENTS AND CONTINGENCIES

In December 2003, the Company executed an agreement with its stock transfer agent to settle all past outstanding obligations for $8,000. The payment was subsequently made in January 2004 per the terms of the agreement. As part of the settlement, the Company entered into an agreement to retain the stock transfer agent through December 2006 at the mutually agreed rate of $625 per month. As of ~~February~~August 2931, ~~2012the~~2012 the Company has an outstanding balance of $ 23,013 with the stock transfer agent.

108

ITEM 2: MANAGEMENTS DISCUSSION AND ANALYSIS

This report contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. NVCN’s actual results could differ materially from those set forth on the forward looking statements as a result of the risks set forth in NVCN Corporation’s filings with the Securities and Exchange Commission, general economic conditions, and changes in the assumptions used in making such forward looking statements.

OVERVIEW

NVCN Corporation (the Company) was incorporated in the State of Delaware on April 20, 1981, with the name Cardio-Pace Medical, Inc. On November 24, 1987, the Company’s name was changed to Novacon Corporation, and on February 20, 2001, the name was changed to NVCN Corporation.

The Company was incorporated in 1981 with authorized capital of 15,000,000 common shares with a par value of $0.01. On February 14, 2001, the shareholders of the Company approved (and on June 20, 2002, the Company effected) a 1 for 12 reverse common stock split, a reduction of common stock par value from $0.01 to $0.001, an increase of authorized capital to 50,000,000 common shares and authorized the board of directors to issue preferred shares of which 10,000,000 with a par value of $0.01 were authorized. The accompanying financial statements reflect all share data based on the 1 for 12 reverse common stock split basis.

The Company was engaged in the business of assembling and distributing disposable drug infusion pumps designed for hospital and home pain management applications, under an exclusive United States manufacturing and marketing agreement with the purported Japanese developer of the proprietary technology. In the second quarter of 2000, the Company discontinued its business operations and since that date has remained inactive.

RESULTS OF OPERATIONS

During the three ~~and nine~~ month ~~periods~~period ending ~~February~~August 2931, 2012 and 2011 the Company had no revenues. General and Administrative expense totaled $1418,~~995~~627 for the three months ~~and $45,015 for the nine month periods~~ ending ~~February~~August 2931, 2012 compared to $3312,~~995~~520 ~~and $61,774~~ for the same ~~periods~~period in 2011. Interest expense was $717 for the three months ~~and $2,152 for the nine months~~ periods ending ~~February~~August 2931, 2012 and $~~1,334~~718for ~~and $3,374for~~ the same ~~periods~~period in 2011. Net loss of the ~~three month~~ period was $1519,~~712~~344 ~~and $47,167~~ for ~~the~~August ~~nine month periods for February 29~~31, 2012 and $3513,~~289~~237 ~~and $64,118~~ for ~~the same periods for~~ 2011. The loss was a result of no revenue and during both 2012 and 2011 along with administrative expenses and interest.

LIQUIDITY AND CAPITAL RESOURCES

At ~~February~~August 2931, 2012, the Company had $15,008 in current assets and current liabilities of $~~269~~306,~~865~~177, resulting in working capital deficit of $~~254~~220,~~857~~927. Shareholders' deficit as of ~~February~~August 2931, 2012 was $~~254~~291,~~857~~169. Except for funds of $5,310 advanced by a related party there exist no agreements or understandings with regard to loan agreements by or with the Officers, Directors, principals, affiliates or shareholders of the Company.

119

Net cash used in operations for the period ending ~~February~~August 2931, 2012 was ~~$9,020~~zero compared to cash used of $~~50,938~~20 for the same period in 2011~~, a decrease of $41,918~~. Net cash used in investing activities for the period ending ~~February~~August 2931, 2012 was zero ~~compared~~as towell ~~$15,000~~as for the same period in 2011. Net cash provided by financing activities during the period ended ~~February~~August 2931, 2012 was ~~$9,000~~zero compared to net cash provided of ~~$65,950~~zero in 2011~~, a decrease of $56,950~~. Financing activity in 2012 consisted of advances from related parties of $5000 and notes payable of $4,000 compared to the issuance of notes payable in 2011of $66,600 and payments to related parties of $650.

Our existing capital may not be sufficient to meet the Company’s cash needs, including the costs of compliance with the continuing reporting requirements of the Securities Exchange Act of 1934, as amended. This condition raises substantial doubt as to the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary if NVCN is unable to continue as a going concern.

EMPLOYEES

As of ~~February~~August 2931, 2012 the Company had no employees

CAPITAL EXPENDITURES

There were no capital expenditures during the quarter ended ~~February~~August 2931, 2012.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSUREES ABOUT MARKET RISK

As a “smaller reporting company” as defined by Item 10 of Regulation S-K NVCN is not required to provide information required under this Item.

ITEM 4T4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Based on their evaluation of our disclosure controls and procedures(as defined in Rule 13a-15e under the Securities Exchange Act of 1934 the "Exchange Act"), our principal executive officer and principal financial officer have concluded that as of the end of the period covered by this quarterly report on Form 10-Q such disclosure controls and procedures were not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms because of the identification of a material weakness in our internal control over financial reporting which we view as an integral part of our disclosure controls and procedures. The material weakness relates to the lack of segregation of duties in financial reporting, as our financial reporting and all accounting functions are performed by an external consultant with no oversight by a professional with accounting expertise. Our CEO/CFO does not possess accounting expertise and our company does not have an audit committee. This weakness is due to the company’s lack of working capital to hire additional staff. To remedy this material weakness, we intend to engage another accountant to assist with financial reporting as soon as our finances will allow.

Changes in Internal Control over Financial Reporting

Except as noted above, there have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during our first quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

1210

PART II – OTHER INFORMATION

ITEM 1: LEGAL PROCEEDINGS

None

ITEM 1A: RISK FACTORS.

There have been no material changes to NVCN’s risk factors as previously disclosed in our most recent 10-K filing for the year ending May 31, ~~2011~~2012.

ITEM 2: UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3: DEFAULTS UPON SENIOR SECURITIES

Not Applicable.

ITEM 4: ~~REMOVE~~ ~~AND~~MINE ~~RESERVE~~SAFETY INFORMATION

None

ITEM 5: OTHER INFORMATION.

None

ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K.

None

Exhibits

Exhibits included or incorporated by reference herein are set forth in the attached Exhibit Index.

1311

SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NVCN Corporation
	NVCN Corporation.
Dated: April 19, 2012	By:	/s/ Gary Borglund
Dated: October 19, 2012	By:	/s/ Gary Borglund
		Gary Borglund, Principal Executive Officer
		and Principal Financial Officer

1412

EXHIBIT INDEX

Number		Description

31		Rule 13a-14(a)/15d-14(a) Certification of Gary Borglund (filed herewith).

32		Section 1350 Certification of Gary Borglund (filed herewith).

101.INS **		XBRL Instance Document

101.SCH **		XBRL Taxonomy Extension Schema Document

101.CAL **		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF **		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB **		XBRL Taxonomy Extension Label Linkbase Document

101.PRE **		XBRL Taxonomy Extension Presentation Linkbase Document

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

1513

Filing Compare · NVCN CORP